Industry & Policy News

[University at Albany (Newswise)] University at Albany scientist Scott Tenenbaum has received $500,000 from the National Institute on Aging to study how aging brain cells shape the progression of Alzheimer’s disease, and advance RNA technology that could inform new therapeutics to prevent and treat Alzheimer's and related dementias.

[PetVivo Holdings, Inc.] PetVivo Holdings, Inc. released the results of a clinical study conducted by Inotiv, Inc. which examined the safety of intra-articular injections of a collagen-elastin hydrogel microparticulate biomaterial into the joints of dogs.

[Mirage News] A Murdoch Children's Research Institute researcher has received an Australia Day honor. Associate Professor Ngaire Elwood has been awarded the Member of the Order of Australia in the General Division for significant service to medicine, particularly through stem cell research.

[Capital News] Political advisors for the Shanghai government have urged relevant parties to work toward making the city a global hub for stem cell research, development and industrialization.

[Nature] On 19 January, the UK Health and Security Agency, the public-health authority, declared a national incident over rising cases of measles. The agency has logged more than 200 cases since 1 October 2023.

[Longeveron Inc] Longeveron Inc. announced it received a notice of patent allowance from the United States Patent and Trademark Office for Medicinal Signaling Cells, the technology behind its lead investigational product Lomecel-BTM. The allowance impacts patients with Aging-related Frailty receiving vaccines for conditions such as COVID and the flu.